Accuracy of saliva for SARS-CoV-2 detection in outpatients and their household contacts during the circulation of the Omicron variant of concern
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , , , , , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/60234 |
Resumo: | This work was funded by the Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro (FAPERJ) [FAPERJ/E26/201.379/2021 JCNE (G.C), [FAPERJ/E‑26/210.146/2020 COVID (P.B); FAPERJ/E‑26/200.935/2022 CNE (P.B), FAPERJ/E26/210.196/2020 (M.S)]; Department of Science and Technology (DECIT) of the Brazilian Ministry of Health (25000.072811/2016‑19) (P.B), The National Council for Scientific and Technological Development (CNPq), Ministry of Science, Technology and Innovation (MCT) [402457/2020‑0] (M.S); INOVA Oswaldo Cruz Foundation (Fiocruz) [VPPCB‑005‑FIO‑20‑2] (M.S); UK Medical Research Council [MR/V033530/1] (J.W and C.S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. |
id |
CRUZ_7c5f844ac1a3bff470312aeabbb3a210 |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/60234 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Calvet, GuilhermeOgrzewalska, MariaTassinari, WagnerGuaraldo, LusieleResende, PaolaFuller, TrevonPenetra, StephanieBorges, MichelePina-Costa, AnielleMartins, EzequiasMoraes, IsabellaSantos, HeloisaDamasceno, LuanaMedeiros-Filho, FernandoEspindola, OtavioMota, FernandoNacife, ValériaPauvolid-Corrêa, AlexWhitworth, JimmySmith, ChrisSiqueira, MarildaBrasil, Patrícia2023-08-25T23:23:40Z2023-08-25T23:23:40Z2023CALVET, Guilherme et al. Accuracy of saliva for SARS-CoV-2 detection in outpatients and their household contacts during the circulation of the Omicron variant of concern. BMC Infectious Diseases, v. 13, p. 1-9, May 2023.1471-2334https://www.arca.fiocruz.br/handle/icict/6023410.1186/s12879-023-08271-3This work was funded by the Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro (FAPERJ) [FAPERJ/E26/201.379/2021 JCNE (G.C), [FAPERJ/E‑26/210.146/2020 COVID (P.B); FAPERJ/E‑26/200.935/2022 CNE (P.B), FAPERJ/E26/210.196/2020 (M.S)]; Department of Science and Technology (DECIT) of the Brazilian Ministry of Health (25000.072811/2016‑19) (P.B), The National Council for Scientific and Technological Development (CNPq), Ministry of Science, Technology and Innovation (MCT) [402457/2020‑0] (M.S); INOVA Oswaldo Cruz Foundation (Fiocruz) [VPPCB‑005‑FIO‑20‑2] (M.S); UK Medical Research Council [MR/V033530/1] (J.W and C.S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Acute Febrile Illnesses Laboratory. Rio de Janeiro, RJ, Brazil.Oswaldo Cruz Foundation. Oswaldo Cruz Institute. Rio de Janeiro, RJ, Brazil / SARS-CoV-2 National Reference Laboratory. Brazilian Ministry of Health (MoH) and Regional Reference Laboratory in Americas. Pan-American Health Organization. Rio de Janeiro, RJ, Brazil.Federal Rural University of Rio de Janeiro. Rio de Janeiro, RJ, Brazil.Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Acute Febrile Illnesses Laboratory. Rio de Janeiro, RJ, Brazil.Oswaldo Cruz Foundation. Oswaldo Cruz Institute. Rio de Janeiro, RJ, Brazil / SARS-CoV-2 National Reference Laboratory. Brazilian Ministry of Health (MoH) and Regional Reference Laboratory in Americas. Pan-American Health Organization. Rio de Janeiro, RJ, Brazil.Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Acute Febrile Illnesses Laboratory. Rio de Janeiro, RJ, Brazil.Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Acute Febrile Illnesses Laboratory. Rio de Janeiro, RJ, Brazil.Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Acute Febrile Illnesses Laboratory. Rio de Janeiro, RJ, Brazil.Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Acute Febrile Illnesses Laboratory. Rio de Janeiro, RJ, Brazil.Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Acute Febrile Illnesses Laboratory. Rio de Janeiro, RJ, Brazil.Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Acute Febrile Illnesses Laboratory. Rio de Janeiro, RJ, Brazil.Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Acute Febrile Illnesses Laboratory. Rio de Janeiro, RJ, Brazil.Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Acute Febrile Illnesses Laboratory. Rio de Janeiro, RJ, Brazil.Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Acute Febrile Illnesses Laboratory. Rio de Janeiro, RJ, Brazil.Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Acute Febrile Illnesses Laboratory. Rio de Janeiro, RJ, Brazil.Oswaldo Cruz Foundation. Oswaldo Cruz Institute. Rio de Janeiro, RJ, Brazil / SARS-CoV-2 National Reference Laboratory. Brazilian Ministry of Health (MoH) and Regional Reference Laboratory in Americas. Pan-American Health Organization. Rio de Janeiro, RJ, Brazil.Oswaldo Cruz Foundation. Oswaldo Cruz Institute. Rio de Janeiro, RJ, Brazil / SARS-CoV-2 National Reference Laboratory. Brazilian Ministry of Health (MoH) and Regional Reference Laboratory in Americas. Pan-American Health Organization. Rio de Janeiro, RJ, Brazil.Oswaldo Cruz Foundation. Oswaldo Cruz Institute. Rio de Janeiro, RJ, Brazil / SARS-CoV-2 National Reference Laboratory. Brazilian Ministry of Health (MoH) and Regional Reference Laboratory in Americas. Pan-American Health Organization. Rio de Janeiro, RJ, Brazil.Departments of Clinical Research and Epidemiology and Public Health. London School of Hygiene and Tropical Medicine. London, UK.Departments of Clinical Research and Epidemiology and Public Health. London School of Hygiene and Tropical Medicine. London, UK.Oswaldo Cruz Foundation. Oswaldo Cruz Institute. Rio de Janeiro, RJ, Brazil / SARS-CoV-2 National Reference Laboratory. Brazilian Ministry of Health (MoH) and Regional Reference Laboratory in Americas. Pan-American Health Organization. Rio de Janeiro, RJ, Brazil.Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Acute Febrile Illnesses Laboratory. Rio de Janeiro, RJ, Brazil.Background While nasopharyngeal (NP) swabs are considered the gold standard for severe acute respiratory coronavirus 2 (SARS‑CoV‑2) real‑time reverse transcriptase‑polymerase chain reaction (RT‑PCR) detection, several studies have shown that saliva is an alternative specimen for COVID‑19 diagnosis and screening. Methods To analyze the utility of saliva for the diagnosis of COVID‑19 during the circulation of the Omicron variant, participants were enrolled in an ongoing cohort designed to assess the natural history of SARS‑CoV‑2 infection in adults and children. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and Cohen’s kappa coefficient were calculated to assess diagnostic performance. Results Overall, 818 samples were collected from 365 outpatients from January 3 to February 2, 2022. The median age was 32.8 years (range: 3–94 years). RT‑PCR for SARS‑CoV‑2 was confirmed in 97/121 symptomatic patients (80.2%) and 62/244 (25.4%) asymptomatic patients. Substantial agreement between saliva and combined nasopharyngeal/ oropharyngeal samples was observed with a Cohen’s kappa value of 0.74 [95% confidence interval (CI): 0.67–0.81]. Sensitivity was 77% (95% CI: 70.9–82.2), specificity 95% (95% CI: 91.9–97), PPV 89.8% (95% CI: 83.1–94.4), NPV 87.9% (95% CI: 83.6–91.5), and accuracy 88.5% (95% CI: 85.0‑91.4). Sensitivity was higher among samples collected from symptomatic children aged three years and older and adolescents [84% (95% CI: 70.5–92)] with a Cohen’s kappa value of 0.63 (95% CI: 0.35–0.91). Conclusions Saliva is a reliable fluid for detecting SARS‑CoV‑2, especially in symptomatic children and adolescents during the circulation of the Omicron variant.engSpringer NatureAccuracy of saliva for SARS-CoV-2 detection in outpatients and their household contacts during the circulation of the Omicron variant of concerninfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleCOVID‑19SARS‑CoV‑2Omicron variantSalivaAccuracyinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZORIGINALve_Guilherme_Calvet_etal_INI_IOC_2023.pdfve_Guilherme_Calvet_etal_INI_IOC_2023.pdfapplication/pdf1015369https://www.arca.fiocruz.br/bitstream/icict/60234/2/ve_Guilherme_Calvet_etal_INI_IOC_2023.pdfd6a883550c0f4e0a23d34cefe081694eMD52LICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/60234/1/license.txt5a560609d32a3863062d77ff32785d58MD51icict/602342023-09-14 15:46:08.222oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-09-14T18:46:08Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.en_US.fl_str_mv |
Accuracy of saliva for SARS-CoV-2 detection in outpatients and their household contacts during the circulation of the Omicron variant of concern |
title |
Accuracy of saliva for SARS-CoV-2 detection in outpatients and their household contacts during the circulation of the Omicron variant of concern |
spellingShingle |
Accuracy of saliva for SARS-CoV-2 detection in outpatients and their household contacts during the circulation of the Omicron variant of concern Calvet, Guilherme COVID‑19 SARS‑CoV‑2 Omicron variant Saliva Accuracy |
title_short |
Accuracy of saliva for SARS-CoV-2 detection in outpatients and their household contacts during the circulation of the Omicron variant of concern |
title_full |
Accuracy of saliva for SARS-CoV-2 detection in outpatients and their household contacts during the circulation of the Omicron variant of concern |
title_fullStr |
Accuracy of saliva for SARS-CoV-2 detection in outpatients and their household contacts during the circulation of the Omicron variant of concern |
title_full_unstemmed |
Accuracy of saliva for SARS-CoV-2 detection in outpatients and their household contacts during the circulation of the Omicron variant of concern |
title_sort |
Accuracy of saliva for SARS-CoV-2 detection in outpatients and their household contacts during the circulation of the Omicron variant of concern |
author |
Calvet, Guilherme |
author_facet |
Calvet, Guilherme Ogrzewalska, Maria Tassinari, Wagner Guaraldo, Lusiele Resende, Paola Fuller, Trevon Penetra, Stephanie Borges, Michele Pina-Costa, Anielle Martins, Ezequias Moraes, Isabella Santos, Heloisa Damasceno, Luana Medeiros-Filho, Fernando Espindola, Otavio Mota, Fernando Nacife, Valéria Pauvolid-Corrêa, Alex Whitworth, Jimmy Smith, Chris Siqueira, Marilda Brasil, Patrícia |
author_role |
author |
author2 |
Ogrzewalska, Maria Tassinari, Wagner Guaraldo, Lusiele Resende, Paola Fuller, Trevon Penetra, Stephanie Borges, Michele Pina-Costa, Anielle Martins, Ezequias Moraes, Isabella Santos, Heloisa Damasceno, Luana Medeiros-Filho, Fernando Espindola, Otavio Mota, Fernando Nacife, Valéria Pauvolid-Corrêa, Alex Whitworth, Jimmy Smith, Chris Siqueira, Marilda Brasil, Patrícia |
author2_role |
author author author author author author author author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Calvet, Guilherme Ogrzewalska, Maria Tassinari, Wagner Guaraldo, Lusiele Resende, Paola Fuller, Trevon Penetra, Stephanie Borges, Michele Pina-Costa, Anielle Martins, Ezequias Moraes, Isabella Santos, Heloisa Damasceno, Luana Medeiros-Filho, Fernando Espindola, Otavio Mota, Fernando Nacife, Valéria Pauvolid-Corrêa, Alex Whitworth, Jimmy Smith, Chris Siqueira, Marilda Brasil, Patrícia |
dc.subject.en.en_US.fl_str_mv |
COVID‑19 SARS‑CoV‑2 Omicron variant Saliva Accuracy |
topic |
COVID‑19 SARS‑CoV‑2 Omicron variant Saliva Accuracy |
description |
This work was funded by the Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro (FAPERJ) [FAPERJ/E26/201.379/2021 JCNE (G.C), [FAPERJ/E‑26/210.146/2020 COVID (P.B); FAPERJ/E‑26/200.935/2022 CNE (P.B), FAPERJ/E26/210.196/2020 (M.S)]; Department of Science and Technology (DECIT) of the Brazilian Ministry of Health (25000.072811/2016‑19) (P.B), The National Council for Scientific and Technological Development (CNPq), Ministry of Science, Technology and Innovation (MCT) [402457/2020‑0] (M.S); INOVA Oswaldo Cruz Foundation (Fiocruz) [VPPCB‑005‑FIO‑20‑2] (M.S); UK Medical Research Council [MR/V033530/1] (J.W and C.S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. |
publishDate |
2023 |
dc.date.accessioned.fl_str_mv |
2023-08-25T23:23:40Z |
dc.date.available.fl_str_mv |
2023-08-25T23:23:40Z |
dc.date.issued.fl_str_mv |
2023 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
CALVET, Guilherme et al. Accuracy of saliva for SARS-CoV-2 detection in outpatients and their household contacts during the circulation of the Omicron variant of concern. BMC Infectious Diseases, v. 13, p. 1-9, May 2023. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/60234 |
dc.identifier.issn.en_US.fl_str_mv |
1471-2334 |
dc.identifier.doi.none.fl_str_mv |
10.1186/s12879-023-08271-3 |
identifier_str_mv |
CALVET, Guilherme et al. Accuracy of saliva for SARS-CoV-2 detection in outpatients and their household contacts during the circulation of the Omicron variant of concern. BMC Infectious Diseases, v. 13, p. 1-9, May 2023. 1471-2334 10.1186/s12879-023-08271-3 |
url |
https://www.arca.fiocruz.br/handle/icict/60234 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Springer Nature |
publisher.none.fl_str_mv |
Springer Nature |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/60234/2/ve_Guilherme_Calvet_etal_INI_IOC_2023.pdf https://www.arca.fiocruz.br/bitstream/icict/60234/1/license.txt |
bitstream.checksum.fl_str_mv |
d6a883550c0f4e0a23d34cefe081694e 5a560609d32a3863062d77ff32785d58 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1813009116386295808 |